Heat Biologics – About the Company

Heat Biologics (NasdaqCM: HTBX) is a biotechnology company developing allogeneic, off-the-shelf immunotherapies for oncology using the its proprietary ImPACT® technology. The Company’s approach is to induce pan-antigen expression and specific activation of cytotoxic T-cells to target and destroy cancer cells. Phase II trials are underway targeting the treatment of third or fourth-line non-small cell lung cancer (NSCLC) and non-muscle invasive bladder cancer (NMIBC).